DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow DVA
DaVita Inc. (DVA) Price to free cash flow
As of 16 October 2026, DaVita Inc. (DVA) trades at a price to free cash flow of 6.7×. Over the past ten years it has ranged from 1.5× (April 2020) to 41.7× (November 2015); the current reading is higher than 30% of that period. That is below the Medical Care Facilities industry median of 13.7× and below the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 5.6× | (27.20%) |
| FY2024 | 7.6× | 36.07% |
| FY2023 | 5.6× | (8.25%) |
| FY2022 | 6.1× | (31.12%) |
| FY2021 | 8.9× | (14.60%) |
| FY2020 | 10.4× | 368.49% |
| FY2019 | 2.2× | (76.44%) |
| FY2018 | 9.4× | (24.38%) |
| FY2017 | 12.4× | 14.45% |
| FY2016 | 10.9× | (36.08%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 8.0× | 30.95% |
| Mar 2026 | 6.1× | 10.12% |
| Dec 2025 | 5.6× | (12.65%) |
| Sep 2025 | 6.4× | (12.00%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.8× |
| DVA DaVita Inc. | 6.7× |
| THC Tenet Healthcare Corporation compare | 7.4× |
| UHS Universal Health Services, Inc. compare | 13.1× |
| PACS PACS Group, Inc. compare | 16.2× |
| CON Concentra Group Holdings Parent, Inc. compare | 17.9× |
| CHE Chemed Corporation compare | 20.6× |
| ENSG The Ensign Group, Inc. compare | 24.4× |
| EHC Encompass Health Corporation compare | 32.9× |
| Medical Care Facilities industry median | 13.7× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on DVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement